SAGE Open Medical Case Reports (Jun 2021)

A case of cutaneous necrosis due to intra-articular hyaluronic acid and treated with hyaluronidase

  • Michelle Aaron,
  • Yu Qing Huang,
  • Danielle Bouffard,
  • Jean-Pascal Costa,
  • Benoît Côté

DOI
https://doi.org/10.1177/2050313X211025110
Journal volume & issue
Vol. 9

Abstract

Read online

A 66-year-old woman presented to the hospital with cutaneous necrosis of her right ankle and foot. Her symptoms began immediately after an intra-articular injection of hyaluronic acid for ankle osteoarthritis, which was performed 6 days before. Histopathology showed an intra-vascular hyaluronic acid embolus. The initial treatment approach was conservative, but the patient’s clinical state degraded. She was thus treated with sub-cutaneous hyaluronidase, the enzyme that degrades hyaluronic acid, which yielded a moderate improvement even though it was administered 22 days after the initial hyaluronic acid injection. Although hyaluronic acid embolism and subsequent cutaneous necrosis are well-known complications of dermal fillers, there are few reported cases of embolism following intra-articular injection. To our knowledge, this is the first time hyaluronidase has been used in this setting.